An Observational Study on Changes in Psychological Parameters in Covid 19 Recovered Patients
DOI:
https://doi.org/10.37506/pyhc2703Keywords:
covid 19 recovered, PTSD, stress, cognitive impairment.Abstract
The rapid escalation of COVID-19 pandemic resulted in a World Health Organization (WHO)-declaring public health emergency of international concern. The present study aimed to measure the prevalence of depression, anxiety, stress, post-traumatic stress disorder and cognitive impairment among the covid19 recovered patients. This observational study included patients with a history of COVID-19 who were admitted in the IPD of Medical College & Hospital, Kolkata. Data was collected from the patients after 14 days from recovering from COVID Patients were assessed through three questionnaire, Depression, Anxiety and Stress Scale - 21 (DASS-21), PTSD Checklist PCL-5 and Montreal Cognitive Assessment (MOCA). Statistical analysis showed significant differences between Anxiety and PTSD score of male and female patients. Significant difference was found in the depression, anxiety and PTSD score, when comparison was made on the basis severity level of Covid. Significant difference was found in the depression, stress and MOCA score, when comparison was made on the basis of educational status of patients. Duration of hospital stay and oxygen therapy were positively associated with anxiety, depression, stress and score while MOCA scores were found to be negatively associated. The result of the present study showed that no significant difference in the psychological variables was observed when comparison was made in terms of comorbidity. In conclusion, we should pay special attention to the mental health status of female patients, severe type individuals as we provide treatments to the COVID-19 patients.
References
.Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., Ciceri F., Rovere-Querini P., Benedetti F. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;24:24. doi: 10.1016/j.bbi.2021.02.021.
.Vanderlind WM, Rabinovitz BB, Miao IY, Oberlin LE, Bueno-Castellano C, Fridman C, et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. CurrOpin Psychiatry. (2021) 34:420–33. doi: 10.1097/YCO.0000000000000713
Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020 Jun 4;382(23):2268-2270. doi: 10.1056/NEJMc2008597. Epub 2020 Apr 15. PMID: 32294339; PMCID: PMC7179967.
Rogers JP ,Chesney E, Oliver D et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020; 7: 611-627
Cao C, Li Y, Liu S, Fan H, Hao L. Epidemiologic features of 135 patients with coronavirus disease (COVID-19) in Tianjin, China. Disaster Med Public Health Prep. 2020;1:1–5. 10.1017/dmp.2020.63
Xiao H, Dai X, Wagenaar BH, Liu F, Augusto O, Guo Y, Unger JM. The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016-2020. Lancet Reg Health West Pac. 2021 Mar 24;9:100122. doi: 10.1016/j.lanwpc.2021.100122. PMID: 34327438; PMCID: PMC8315657.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en